Sign in

CIK 0001434316

  • Non-accelerated filer
  • Smaller reporting company

FATE THERAPEUTICS INC

Sign in to watch
Ticker
FATE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
651311552
Phone
+1 858-875-1803
Business address
12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, 92131
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$13,525
in 1 filing

Net −$13,525. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Adawi Kamal −$14K Chief Financial Officer sold 7% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-03-14 Valamehr Bahram Chief R&D Officer Sale −3,067 $31.66 $97K 185,089
2022-03-14 Valamehr Bahram Chief R&D Officer Sale −2,195 $32.49 $71K 182,894
2022-03-14 Valamehr Bahram Chief R&D Officer Sale −2,960 $33.30 $99K 179,934
2022-03-14 Valamehr Bahram Chief R&D Officer Sale −100 $34.04 $3K 179,834
2022-03-14 Valamehr Bahram Chief R&D Officer Option exercise · Stock Option (Right to Buy) −25,000 36,156
2022-03-10 MENDLEIN JOHN Director Option exercise +31,562 $1.63 $51K 191,017
2022-03-10 MENDLEIN JOHN Director Sale −19,493 $34.73 $677K 171,524
2022-03-10 MENDLEIN JOHN Director Sale −12,069 $35.48 $428K 159,455
2022-03-10 MENDLEIN JOHN Director Option exercise · Stock Option (Right to Buy) −31,562 0
2022-01-25 Valamehr Bahram See Remarks Grant or award +33,302 179,834
2022-01-25 Valamehr Bahram See Remarks Grant or award · Stock Option (Right to Buy) +53,058 53,058
2022-01-25 Chu Yu-Waye Chief Medical Officer Grant or award +33,302 155,095
2022-01-25 Chu Yu-Waye Chief Medical Officer Grant or award · Stock Option (Right to Buy) +53,058 53,058
2022-01-25 Plavsic Mark Chief Technical Officer Grant or award +33,302 130,842
2022-01-25 Plavsic Mark Chief Technical Officer Grant or award · Stock Option (Right to Buy) +53,058 53,058
2022-01-25 Dulac Edward J III Chief Financial Officer Grant or award +33,302 141,936
2022-01-25 Dulac Edward J III Chief Financial Officer Grant or award · Stock Option (Right to Buy) +53,058 53,058
2022-01-25 Wolchko J Scott President and CEO Grant or award · Stock Option (Right to Buy) +289,403 289,403
2022-01-25 TAHL CINDY See Remarks Grant or award +33,302 189,151
2022-01-25 TAHL CINDY See Remarks Grant or award · Stock Option (Right to Buy) +53,058 53,058

Page 12 of 26 · 503 trades